Poietis

Poietis cherche un repreneur ! Dépôt des dossiers avant le Vendredi 27 Décembre 2024. Comme malheureusement beaucoup d'acteurs de la biotech et de la medtech, Poietis fait face depuis plusieurs mois à d'importantes contraintes financières et a dû se mettre sous la protection du tribunal de commerce de Bordeaux. Plus d'informations 👇 https://lnkd.in/d_tykf8Z

Merci Cécile Hellouin de Menibus pour cette mise en lumière !

⚠ Webinar Agenda: NGB-R Bioprinting Systems - Date: Oct 2nd Wednesday, 12 PM EST - Speaker: Fabien Guillemot, CEO Poietis - Check here: https://lnkd.in/eb9SdJwM - Register here: https://lnkd.in/ev3X_Qq4 - Abstract: The Next-Generation Bioprinting (NGB) Platform is designed to combine the advantages of Laser-Assisted Bioprinting (LAB) technology—such as high resolution and enhanced cell viability— with other bioprinting technologies like bioextrusion. This integration enables the fabrication of complex multi-cellular 3D constructs. Featuring robotic automation and innovative fluidics devices, the NGB platform enables the transition of the bioprinted products from the laboratory to the clinic. The commercial NGB-R system is designed for developing bioprinting procedures at the preclinical stage that are translatable to the clinical-ready NGB-C system. This system complies with Good Manufacturing Practices (GMP) for Advanced Therapy Medicinal Products (ATMPs). In this webinar, we will showcase this translation capacity through bioprinting of skin and cartilaginous multicellular spheroids for building larger tissue structures. #Spheroids #TissueEngineering #HealthTech #LifeSciences #Bioprinting #Biomanufacturing

We are thrilled to share that we extended our distribution agreement with HVD Life Science Vertriebs GmbH (Part of the HVD Group of Companies) through its sister company HVD Life Sciences Hongkong in ASIA! Initially aimed to distribute our NGB-R platform in Austria and Germany, we will now collaborate together to also bring our innovative bioprinting system in Thailand, Malaysia and South-Korea, territories where HVD is present and has an extensive network in the Life Sciences community. Let's shape the future of biomedical and translational research together! #Biotech #Innovation #HealthTech #LifeSciences #Bioprinting

We are very proud to announce the recent publication of an article in Biofabrication journal, the official journal of the International Society for Biofabrication (ISBF: https://lnkd.in/dW4KTGb)! Entitled "Laser-assisted bioprinting of targeted cartilaginous spheroids for high density bottom-up tissue engineering" this work is one of the outcomes of an ongoing collaboration with KU Leuven, and completed within the H2020 JOINTPROMISE Project. Please check out the article: https://lnkd.in/e5nxvMfW In this study, we established a laser-assisted bioprinting approach using multicellular spheroids as building blocks. By taking advantage of a new target and shoot system, multilayered constructs containing high density cell spheroids were fabricated. Modular tissue engineering using multicellular spheroids shows great promise for the bioengineering of functional tissue implants; this study provides a solid foundation for further development of laser-assisted bioprinting and may revolutionize the bottom-up biofabrication of controlled living and functional tissue assemblies. Thank you to Poietis team, Gabriella Nilsson Hall, Ioannis Papantoniou and Frank Luyten at KUL! The concept of the JointPROMISE project: https://lnkd.in/eeW6V64S #bioprinting #ATMPs #LaserAssistedBioprinting #biomanufacturing #spheroids

Our CEO Fabien Guillemot had the opportunity to present a webinar on Monday for the US Department of Veterans Affaires: VA Biofabrication Community of Science (BCoS): https://lnkd.in/e6JiFpkx. The speech was about "Bioprinting translation to the clinic: Example of an autologous bioprinted skin substitute manufactured with the Next-Generation Bioprinting (NGB) platform" This Monthly Series is an initiative to share VHA experience and expertise in the BioFabrication arena aimed at creating network and building up a space of reference in the field. It was an amazing audience of researchers and clinicians to discuss the bioprinting translation to the clinic and how Poietis technology and developments can open new avenues in Regenerative Medicine! Thank you to the organizers and especially Nicanor I. Moldovan and Kimberlee Potter, PhD. #bioprinting #tissueengineering #deeptech #biomanufacturing #LaserAssistedBioprinting

We are pleased to announce the launch of our new website! 🖥 The main goal of this newly redesigned website is to provide visitors with a simple and user-friendly interface to present our company, unique bioprinting technology and clear information about our NGB platform and products ! Indeed we sell bioprinters : NGB-R and NGB-C. Please check it out : www.poietis.com We will update it with helpful and new information, so stay tuned. In the meantime should you need additional information please contact us at ngb-platform@poietis.com #Bioprinting #LaserAssistedBioprinting #TissueEngineering #RegenerativeMedicine

📢 Delighted to be able to announce the first installation of NGB-R in Italy, at the University of Chieti-Pescara ! The platform was installed within the Ud’ATechLab of the Department of Innovative Technologies in Medicine and Dentistry, which was recently created by Dr. Tonino Traini, CDT-MDT;DDS;PhD, Associate Professor, with the aim of applying innovative technologies in R&D in the fields of medicine and dentistry with possible impacts on human health. 🚀Following installations in France, Spain, the Netherlands, and Lithuania, Italy becomes the fifth European nation to welcome the NGB-R platform ! 👉For more information about our Bioprinting platform, contact us at ngb-platform@poietis.com #NextGenBioprintingSystem #Innovation #HealthTech #Italy

🚀 Going back from TERMIS 24 ! We had a great time at the 7th TERMIS World Congress in Seattle, USA, with experts from around the globe to discuss the latest advancements in tissue engineering and regenerative medicine ! We would like to thank you our North America partner Scintica and the organizers Tissue Engineering and Regenerative Medicine International Society, Inc. (TERMIS). Thank you also to our collaborators and customers who stoped by to our booth to discuss their current and future projects with NGB! #TERMIS #TissueEngineering #RegenerativeMedicine #Poietis #Innovation 

🚨 Welcome to the 7th TERMIS World Congress #TERMIS24 ! Tomorrow, join Fabien Guillemot, Poietis' CEO, for an exciting talk about how to translate your bioprinted products from the laboratory to clinic, thanks to our Next Generation Bioprinting platform ! ➡ June 26, 6:45 PM, Hall 4A, Seattle Convention Center 🗓 Seattle Convention Center, June 25 - 28, meet us at Booth 101 (with our USA partner Scintica) !